Results 231 to 240 of about 5,849,239 (280)

Inflammatory bowel disease outcomes among hospitalized homeless individuals. [PDF]

BMC Gastroenterol
Mungle T, Charu V, Okafor PN.
europepmc   +1 more source

Transcription Factor HOXC11 Drives Colorectal Cancer Progression and Metastasis via CAMK2A‐Dependent CXCL5 Upregulation

Advanced Science, EarlyView.
HOXC11 drives colorectal cancer progression by transcriptionally activating CAMK2A, which triggers NF‐κB–dependent CXCL5 upregulation. CXCL5–CXCR2 signaling further reinforces HOXC11 expression through the ERK1/2–SP1 axis, forming a prometastatic positive feedback loop that is effectively disrupted by combined CAMK2A and CXCR2 inhibition.
Qingyang Sun, Hengjie Xu, Sheng Yang, Jiahui Zhou, Chuanxin Tian, Hongxu Nie, Chi Jin, Tuo Wang, Zhihao Chen, Junwei Tang, Yifei Feng, Xiaowei Wang, Yueming Sun   +12 more
wiley   +1 more source

Interleukin-23 Inhibitors in Inflammatory Bowel Disease. [PDF]

BioDrugs
Puca P, Parello S, Colantuono S, Tursi A, Coppola G, Lopetuso LR, Scaldaferri F, Gasbarrini A, Papa A.   +8 more
europepmc   +1 more source

Design and Application of Nanozymes: Current Trends and Cutting‐Edge Breakthroughs

Advanced Science, EarlyView.
Kelong Fan, Hui Wei, Xiyun Yan
wiley   +1 more source

Macrophage-driven inflammation in inflammatory bowel disease: mechanisms and therapeutic opportunities. [PDF]

Front Bioeng Biotechnol
Rossi M, Spanò A, Fortun A, Camilleri N, Magatti M, Papait A, Silini A, Parolini O.   +7 more
europepmc   +1 more source

Upadacitinib in Asian inflammatory bowel disease practice: encouraging real-world efficacy. [PDF]

Intest Res
Kim ES.
europepmc   +1 more source

The potential connection between inflammatory bowel disease and Alzheimer's disease: mechanistic insights and therapeutic implications. [PDF]

Front Immunol
Peng L, Wu Z, Yuan X, Zhou C, Fu H.
europepmc   +1 more source

Correction: The role of dietary factors in the prevention and management of inflammatory bowel disease: a comprehensive review. [PDF]

Nutr Metab (Lond)
Nattagh-Eshtivani E, Barghchi H, Mansouri AH, Rahbarinejad P, Mokari-Yamchi A, Barati M, Rashidmyvan M, Esfehani AJ, Mohammadzadeh A, Clyton Z, Marabi P, Talebi S, Pahlavani N.   +12 more
europepmc   +1 more source

An Overview of the Rationale and Outcomes of Residential Camps for Children with Inflammatory Bowel Disease. [PDF]

Pediatr Gastroenterol Hepatol Nutr
Crouzen ET, Day AS.
europepmc   +1 more source